Kalvista Pharmaceuticals Inc share price logo

Kalvista Pharmaceuticals Inc Share Price

NASDAQ: KALV

Small Cap

$13.37

-0.13

(-0.96%)

as on

Kalvista Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $13.38
    $13.93
    downward going graph

    -0.07%

    Downside

    4.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.3
    $17.28
    downward going graph

    45.40%

    Downside

    29.24%

    Upside

    downward going graph

Kalvista Pharmaceuticals Inc share price movements today

Previous Close
$13.50
Open
$13.63
Volume
377.0K
Day's Low - High
$13.38 - $13.93
52 Week Low - High
$7.3 - $17.28

Kalvista Pharmaceuticals Inc Historical Returns

1 Month Return
+ 8.77 %
3 Month Return
+ 15.36 %
1 Year Return
+ 32.54 %
3 Year Return
-6.54 %
5 Year Return
+ 4.63 %

Kalvista Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Kalvista Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$707.8M

EPS (TTM)

-3.56

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-14.79

Industry PE ratio

0.4226599326599327

P/B Ratio

0

PEG Ratio

0

EBITDA

-201.8M

Revenue (TTM)

1.4M

Profit Margin

0.00%

Return On Equity TTM

7374400.00%

Kalvista Pharmaceuticals Inc Stock Valuation

Track how Kalvista Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Kalvista Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Today (-14.79x)

September 17, 2025

Industry (0.42x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -14.79x

Kalvista Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kalvista Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$707.8M4.63%-14.790.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Kalvista Pharmaceuticals Inc Stock including INR - Dollar returns

The Kalvista Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kalvista Pharmaceuticals Inc investment value today

Current value as on today

₹1,31,088

Returns

₹31,088

(+31.09%)

Returns from Kalvista Pharmaceuticals Inc Stock

₹26,490 (+26.49%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Kalvista Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Kalvista Pharmaceuticals Inc. Average target price of $31.67

Kalvista Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Kalvista Pharmaceuticals Inc.

What analysts predicted

57.78%UPSIDE

Target Price

$31.67

Current Price

$13.37

Analyzed by

12 Analysts

Target

$31.67

Kalvista Pharmaceuticals Inc target price $31.67, a slight upside of 57.78% compared to current price of $13.37. According to 12 analysts rating.

Kalvista Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Kalvista Pharmaceuticals Inc Stock has increased by 135% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:135% versus previous 30 day period

Kalvista Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Apr 2023
Jul 2023
Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Total Revenue
-
-
-
-
1
-
-
-
-
1
Gross Profit
0
0
0
0
0
0
-
-
0
0
Operating Income
-31
-29
-29
-33
-48
-44
-45
-42
-55
-59
EBITDA
-31
-28
-29
-32
-44
-43
-45
-41
-42
-59
Interest Expense
1
-
-
-
-
-
-
2
2
3
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-26
-25
-27
-29
-44
-40
-42
-44
-53
-57
Income Tax Expense
13
-1
0
-
0
-
-
4
0
2
Net Income
-40
-25
-27
-29
-44
-40
-42
-48
-52
-60
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-3702.32%
0.00%
0.00%
0.00%
0.00%
-4214.31%

Kalvista Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Apr 2016
Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Total Revenue
2
1
8
16
12
12
-
-
-
-
Gross Profit
2
1
8
16
12
12
0
0
-86
0
Operating Income
-15
-22
-18
-29
-40
-57
-96
-110
-140
-187
EBITDA
-15
-22
-18
-29
-40
-45
-81
-92
-134
-173
Interest Expense
3
3
2
9
10
0
1
17
-
5
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-18
-15
-20
-29
-46
-82
-92
-135
-180
Income Tax Expense
-5
-5
-1
0
0
-1
-13
-18
-8
3
Net Income
-11
-18
-15
-20
-29
-44
-68
-74
-126
-183
Net Profit Margin
-536.15%
-1236.90%
-188.29%
-129.08%
-229.44%
-350.62%
0.00%
0.00%
0.00%
0.00%

Kalvista Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jul 2023
Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Net Income
-25
-27
-29
-44
-40
-42
-48
-52
-60
Operating Cash Flow
-26
-19
-27
-15
-40
-39
-32
-40
-54
Investing Cash Flow
19
28
-6
-126
37
48
8
-3
21
Financing Cash Flow
0
0
0
150
3
0
151
4
23
Change in Cash
-6
8
-34
8
0
9
126
-35
-7

Kalvista Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Net Income
-18
-15
-20
-29
-46
-82
-92
-126
-183
Operating Cash Flow
-23
10
-36
-44
-30
-78
-75
-89
-152
Investing Cash Flow
34
-1
-69
16
-147
57
41
-84
91
Financing Cash Flow
0
8
87
11
212
1
58
150
159
Change in Cash
9
20
-19
-16
34
-19
25
-24
100

Global Institutional Holdings in Kalvista Pharmaceuticals Inc

Funds
Holdings
VR Adviser, LLC
13.42%
TANG CAPITAL MANAGEMENT LLC
9.89%
Suvretta Capital Management, LLC
9.84%
Vestal Point Capital LP
9.51%
Capital World Investors
6.36%

Kalvista Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 12 September

    Fri, 06:16 PM

    -

    Analyst Andrew Fein maintains Buy rating on KalVista, citing strong early launch metrics for Ekterly and a price target of $27.

Insights on Kalvista Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 42.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 126.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KALV stock has moved down by -8.8%

About Kalvista Pharmaceuticals Inc

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
OrganisationKalvista Pharmaceuticals Inc
Headquarters55 Cambridge Parkway, Cambridge, MA, United States, 02142
IndustryHealth Technology
CEOMr. Benjamin L. Palleiko
E-voting on sharesClick here to vote

Key Management of Kalvista Pharmaceuticals Inc

Name

Title

Mr. Brian Krex J.D.

General Counsel

Ms. Rachel M. Morten

Senior Vice President of Regulatory Affairs & QA

Dr. Christopher M. Yea Ph.D.

Chief Development Officer

Dr. Michael D. Smith Pharm.D.

Senior Vice President of Development

Mr. Brian Piekos

Chief Financial Officer

Dr. Paul K. Audhya M.B.A., M.D.

Chief Medical Officer

Mr. Ryan Baker

Head of Investor Relations

Mr. Benjamin L. Palleiko

CEO & Director

Jarrod Aldom

Vice President of Corporate Communications

Ms. Nicole Sweeny

Chief Commercial Officer

FAQs

What is Kalvista Pharmaceuticals Inc share price today?

Kalvista Pharmaceuticals Inc share price today is $13.37 as on at the close of the market. Kalvista Pharmaceuticals Inc share today touched a day high of $13.93 and a low of $13.38.

What is the 52 week high and 52 week low for Kalvista Pharmaceuticals Inc share?

Kalvista Pharmaceuticals Inc share touched a 52 week high of $17.28 on and a 52 week low of $7.3 on . Kalvista Pharmaceuticals Inc stock price today i.e. is closed at $13.37,which is 22.63% down from its 52 week high and 83.15% up from its 52 week low.

What is Kalvista Pharmaceuticals Inc's market capitalisation today?

Kalvista Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Kalvista Pharmaceuticals Inc Stock (KALV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kalvista Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalvista Pharmaceuticals Inc Shares that will get you 0.1122 shares as per Kalvista Pharmaceuticals Inc share price of $13.37 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kalvista Pharmaceuticals Inc Stock (KALV) from India?

Indian investors can start investing in Kalvista Pharmaceuticals Inc (KALV) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Kalvista Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kalvista Pharmaceuticals Inc share’s latest price of $13.37 as on September 18, 2025 at 1:29 am IST, you will get 0.7479 shares of Kalvista Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Kalvista Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Kalvista Pharmaceuticals Inc stock has given 4.63% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?